secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apellis Pharmaceuticals, Inc. (APLS)
CIK:        0001492422
Form:       8-K
Filed at:   2021-08-30T23:59:59+00:00
Accession:  0001193125-21-259951
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Apellis appoints Jim Chopas as VP, Corporate Controller and CAO
---------------------------------------------------------------

- Jim Chopas named VP, Corporate Controller and principal accounting officer, effective August 30, 2021.
- Annual base salary of $315,000; target bonus 30% of base; one-time sign-on bonus of $50,000.
- Granted option for 21,750 shares and RSU for 7,600 shares, both vesting over four years.
- Previously served as VP, principal financial and accounting officer and treasurer at Radius Health.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1492422/000119312521259951/0001193125-21-259951-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1492422/000119312521259951/d222326d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-259951

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer